Please provide your email address to receive an email when new articles are posted on . This is a case of a 7-year-old girl referred to our clinic in 2018 for an aggressive left distal femur mass. The ...

High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to avapritinib, a drug already approved by the US FDA. The corresponding study was published ...

Boston, MA – A groundbreaking study led by researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and the Broad Institute of MIT and Harvard has uncovered critical insights ...

In an effort to combat one of the most lethal forms of pediatric brain cancer, researchers at the UCLA Health Jonsson Comprehensive Cancer Center are launching a first-of-its-kind clinical trial to ...

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, often resistant to treatment in advanced cases. Researchers have identified thiostrepton (TST), a ribosome-targeting ...

A 13-year-old boy with no history presented after 4 days of progressively worsening whole body rash.Nine days before ...

The FDA's designation for NEO100 highlights the urgent need for treatments for pediatric-type diffuse high-grade gliomas, a rare and aggressive brain cancer. NeOnc Technologies may receive a Rare ...

An analysis of the pediatric emergency care gap and its impact on outcomes, with evidence-based strategies to improve ...